UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
APRIL 14, 2016
Date of Report (Date of earliest event reported)
MESA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 0-11740
COLORADO |
|
84-0872291 |
12100 WEST SIXTH AVENUE, LAKEWOOD, COLORADO |
|
80228 |
Registrant’s telephone number, including area code: (303) 987-8000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|_| |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|_| |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|_| |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|_| |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 5.03 |
AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR |
(a)(1) Effective on April 14, 2016, the Board of Directors of Mesa Laboratories, Inc. (the “Company”) amended and restated the Company’s Bylaws which dated back to 1982 pursuant to the provisions of Article Thirteenth thereof. The amended and restated Bylaws are attached hereto as Exhibit 3(ii).
(a)(2) The following is a description of the material provisions of the Bylaws changed by the amendment and restatement:
1. |
Section 2.3 amended the shareholding requirement of shareholders to request a special meeting of shareholders from not less than fifty percent of the voting shares issued and outstanding to ten percent. |
ITEM 9.01 |
FINANCIAL STATEMENTS AND EXHIBITS |
(d) |
Exhibits: |
3(ii). Amended and Restated Bylaws of Mesa Laboratories, Inc. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DATE: April 14, 2016 |
|
Mesa Laboratories, Inc. |
|
Registrant | |||
|
|
|
|
|
|
/s/ JOHN J. SULLIVAN |
|
|
BY: |
John J. Sullivan, |
|
|
|
President and Chief Executive Officer |
|